Ionis Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Ionis Pharmaceuticals patents 146 in total
| Status | Patent |
|---|---|
Application | Utility: MODULATORS OF FOXP3 EXPRESSION Filling date: 9 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: MODULATION OF THE NOTCH SIGNALING PATHWAY FOR TREATMENT OF RESPIRATORY DISORDERS Filling date: 9 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION Filling date: 9 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS Filling date: 9 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: MODULATORS OF COMPLEMENT FACTOR B Filling date: 9 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: MODULATORS OF PNPLA3 EXPRESSION Filling date: 9 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION Filling date: 9 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION Filling date: 9 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPODYSTROPHY POPULATIONS Filling date: 9 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: COMPOSITIONS FOR MODULATING ATAXIN 2 EXPRESSION Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: Compositions and Methods for Modulating MECP2 Expression Filling date: 9 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN Filling date: 9 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN2 EXPRESSION Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION Filling date: 9 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2) Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION Filling date: 9 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS Filling date: 9 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: MODULATION OF FACTOR 11 EXPRESSION Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: ANTISENSE COMPOUNDS TARGETING GENES ASSOCIATED WITH FIBRONECTIN Filling date: 9 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: MODIFIED CRISPR RNA AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION Filling date: 9 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 9 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: Modulators of APOL1 Expression Filling date: 9 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: OLIGOMERIC COMPOUNDS COMPRISING ALPHA-BETA-CONSTRAINED NUCLEIC ACID Filling date: 9 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: MODULATION OF LNC05 EXPRESSION Filling date: 9 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: MODULATION OF TMPRSS6 EXPRESSION Filling date: 9 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR USE IN DYSTROPHIN TRANSCRIPT Filling date: 9 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF SMN2 Filling date: 9 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF TRANSCRIPT PROCESSING Filling date: 9 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS Filling date: 9 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION Filling date: 9 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS Filling date: 9 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION Filling date: 9 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: MODULATION OF HUNTINGTIN EXPRESSION Filling date: 9 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION Filling date: 9 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: MODULATORS OF DNM2 EXPRESSION Filling date: 9 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: MODULATION OF PREKALLIKREIN (PKK) EXPRESSION Filling date: 9 Sep 2025 Issue date: 1 Aug 2019 |
Showing 100 to 146 of 146 patents.